Dr. Jia Luo
Claim this profileDana-Farber Cancer Institute
Studies Skin Cancer
Studies Uterine Tumors
6 reported clinical trials
11 drugs studied
Area of expertise
1Skin Cancer
Stage IV
KRAS positive
NUT gene translocation positive
2Uterine Tumors
Stage IV
KRAS positive
Stage III
Affiliated Hospitals
Clinical Trials Jia Luo is currently running
EP31670
for Advanced Cancer
A Phase 1, first-in-human study of EP31670, a dual BET and CBP/p300 inhibitor in patients with targeted advanced solid tumors and Hematological Malignancies
Recruiting1 award Phase 1
LY4050784
for Advanced Cancer
The main purpose of this study is to find out whether the study drug, LY4050784, is safe, tolerable and effective in participants with locally advanced or metastatic solid tumors with a BRG1 (Brahma-related gene 1, also known as SMARCA4) alteration who have previously received, do not qualify for, or are refusing standard of care treatments, or there is no standard therapy available for the disease. The study is conducted in two parts - phase Ia (dose-escalation) and phase Ib (dose-optimization, dose-expansion). The study will last up to approximately 4 years.
Recruiting1 award Phase 12 criteria
More about Jia Luo
Clinical Trial Related2 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Jia Luo has experience with
- ZEN003694
- Cisplatin
- Etoposide
- Abemaciclib
- EP31670
- Cetuximab
Breakdown of trials Jia Luo has run
Skin Cancer
Uterine Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jia Luo specialize in?
Jia Luo focuses on Skin Cancer and Uterine Tumors. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are KRAS positive.
Is Jia Luo currently recruiting for clinical trials?
Yes, Jia Luo is currently recruiting for 4 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Jia Luo has studied deeply?
Yes, Jia Luo has studied treatments such as ZEN003694, Cisplatin, Etoposide.
What is the best way to schedule an appointment with Jia Luo?
Apply for one of the trials that Jia Luo is conducting.
What is the office address of Jia Luo?
The office of Jia Luo is located at: Dana-Farber Cancer Institute, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana-Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.